COWEN
COLLABORATIVE INSIGHTS February 25, 2019

controls can be implemented when producing compounds with a biosynthesis method
similar to the processes in place for pharmaceutical regulation.

2

The many perceived advantages of synthetic cannabinoid creation have led to a series of
companies entering the market, as described below.

Figure 10 Selected Synthetic Biology Cannabinoid Companies

Company Notes

Cellibre Cellibre is a next-generation cellular agriculture company. Employing an organism-agnostic approach, Cellibre turns cells
into specialized, sustainable factories for the manufacture of globally significant products at scale.

Ginkgo Bioworks Ginkgo is a Boston-based company that designs custom microbes for customers across multiple markets, developing new
organisms that replace technology with biology.

Hyasynth Biologicals Located in Montreal, Hyasynth Biologicals uses the technologies from traditional and modern biology combined with
computational analysis to develop organisms at the fastest possible speed.

InMed Pharmaceuticals | InMed Pharmaceuticals is a biopharmaceutical company that specializes in the discovery and development of novel,
cannabinoid-based therapeutics for the treatment of diseases with high unmet medical need.

Librede Librede has developed a yeast-based cannabinoid production and drug discovery platform to create chemical compounds
that target the endocannabinoid system. Libredeâ€™s modular technology enables large scale production of natural
cannabinoids in a more economic and environmentally sustainable way

Renew Biopharma Renew Biopharma harnesses the biological pathway to produce natural and novel cannabinoids that cross the blood
brain barrier and target specific receptors associated with neuroinflammation and chronic pain.

Teewinot Life Sciences Tampa-based Teewinot combines its biosynthetic processes with sophisticated chemical synthesis to produce proprietary
cannabinoid analogs and prodrugs at commercial scale.

Amyris Amyris is an industrial biotechnology company that has used sugarcane fermentation to create hydrocarbon molecules
and produces an array of specialty ingredients and consumer products.

Source: Cowen and Company

Producing Cannabinoids Using Synthetic Biology

Synthetic biology methods use fermentation to produce cannabinoids with identical
chemical structures to those found in plants.

Biocatalytic Cannabinoid Pathways

The first step of the synthetic cannabinoid production requires identification and
extraction of the desired cannabinoid biosynthetic pathways from a cannabis varietal.
The biosynthesis of cannabinoid molecules in a microbe could require four or more
cannabinoid metabolic pathways. When the pathways are selected, their corresponding
DNA sequences need to be cloned from the cannabis varietal and spliced into the
microbial DNA.

Cannabinoids could be produced biocatalytically using the following mechanism:
i. Inthe first pathway, glucose is converted into G3P and pyruvate via glycolysis.
These two compounds are then utilized to produce the precursors geranyl

pyrophosphate (GPP), and/or neryl pyrophosphate (NPP).

ii. Glycolysis of glucose also produces Acetyl CoA, which can catalyze biosynthesis
of the second group of precursors: olivetolic acid (OA) and divarinic acid (DVA).

COWEN.COM 19

HOUSE_OVERSIGHT_024835
